Loading Chart Rhythms
Preparing market rhythm analysis...
Preparing market rhythm analysis...
Full Rhythm Report
STE • Stock • Health Care / Health Care Equipment
Executive Summary
Supportive setup, but not clean. STE has a positive read, but risk signals need to stay controlled for the rhythm to remain strong.
Price Rhythm Chart
Chart Rhythms is showing the current market read with live or fallback quote data.
Strategy Scorecard
Daily Setup
Supportive
Swing Setup
Building
Long-Term Setup
Constructive
Confidence
Medium
Risk Level
Moderate
Today Strategy
Today’s setup is supportive. The latest articles are giving the stock a positive tone, with growth expectations, earnings expectations, and valuation risk acting as the main driver. The daily read stays useful only if fresh headlines keep supporting the same idea.
Swing Strategy
For the next few weeks to months, the swing setup depends on repetition. If growth expectations, earnings expectations, and valuation risk keeps appearing across new articles, the read strengthens. If the theme fades or risk language rises, the setup weakens.
Long-Term Strategy
For the long-term view, the system is watching whether Steris's bigger story remains durable. The current narrative is connected to growth expectations, earnings expectations, and valuation risk, but the long-term read still depends on valuation, competition, margins, execution, and whether future sources continue supporting the thesis.
These are the latest sources connected to this strategy report.
Source: Stock Titan • Published: 2026-06-08
STERIS plc senior executive John Adam Zangerle had 401 ordinary shares withheld for tax purposes on June 4, 2026, related to the vesting of 1,376 restricted shares. These shares were valued at $212.24 each and the withholding is a routine transaction to cover employment or tax laws without an open-market sale. After this transaction, Zangerle directly holds 36,678 ordinary shares, including 8,239 restricted shares that will vest in tranches through June 4, 2029.
View original source →Source: Stock Titan • Published: 2026-06-08
Kenneth E. Kohler, SVP & GM, AST at STERIS plc, reported a routine tax-related share disposition. On June 4, 2026, 150 ordinary shares were withheld from 513 vested restricted shares to cover taxes, valued at $212.24 per share. Following this, Kohler directly holds 11,332 ordinary shares, including 3,972 restricted shares set to vest between 2027 and 2029.
View original source →Source: Stock Titan • Published: 2026-06-08
Help improve this analysis
This feedback is saved locally for the MVP. Later, Chart Rhythms can use this feedback to improve the strategy engine.
Important:
Chart Rhythms provides source-based market summaries for research and informational purposes only. This is not financial advice and not a recommendation to buy, sell, or hold any security.
STERIS plc President and CEO Daniel A. Carestio sold a net of 4,428 Ordinary Shares in open-market transactions on June 4 and June 5, 2026, totaling approximately $947,000. He also had 1,889 shares withheld for tax purposes related to restricted shares that vested. Following these transactions, Carestio directly owns 63,647 Ordinary Shares, with 39,893 of them remaining restricted and scheduled to vest in tranches through June 4, 2029.
Source: Stock Titan • Published: 2026-06-08
STERIS plc Senior Vice President Julia Madsen reported a tax-withholding transaction where 195 ordinary shares were disposed of at $212.24 per share to cover taxes on 542 restricted shares that vested on June 4, 2026. Following this, Madsen directly holds 12,257 ordinary shares, with 4,190 still restricted and set to vest in tranches between 2027 and 2029. This transaction is a routine settlement related to equity awards, not an open-market sale.
View original source →Source: Stock Titan • Published: 2026-06-08
STERIS plc Senior Vice President Mary Clare Fraser had 600 ordinary shares withheld for tax purposes on June 4, 2026, associated with the vesting of 1,360 restricted shares. The shares were valued at $212.24 each, totaling $127K for tax liability settlement. After this transaction, Fraser directly owns 13,716 ordinary shares, with 5,359 remaining restricted and scheduled to vest between 2027 and 2029.
View original source →Source: MarketBeat • Published: 2026-06-07
Bank of New York Mellon Corp reduced its stake in STERIS plc (NYSE:STE) by 2.7% in the fourth quarter, holding 542,859 shares valued at $137.6 million. STERIS reported mixed quarterly results, with EPS of $2.83 against an estimated $2.86, while revenue met expectations at $1.59 billion, up 6.7% year over year. The company declared a quarterly dividend of $0.63 per share and currently holds a "Moderate Buy" consensus rating with a target price of $278.00 from analysts.
View original source →Source: Stock Titan • Published: 2026-06-06
A recent Form 144 filing from STERIS plc (STE) indicates an insider sale by Daniel A. Carestio, disclosing transactions related to equity compensation. The filing shows a restricted stock lapse of 1,374 shares on June 2, 2026, and a sale of 3,054 shares on June 4, 2026, totaling $655,511.
View original source →Source: Stock Titan • Published: 2026-06-06
STERIS plc Senior Vice President and General Counsel, John Adam Zangerle, had 365 ordinary shares withheld for tax purposes on June 3, 2026. These shares were part of 1,252 restricted shares that vested, and the value for tax withholding was based on the NYSE closing price of $210.19 per share. After this transaction, Zangerle directly holds 37,079 ordinary shares, with remaining restricted shares scheduled to lapse in tranches through 2029.
View original source →